Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Afeyan Noubar
Relationship:   Director, 10% Owner
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   8,070,025    

Indirect Shares

  111,880,829      
Direct Value   $20,069,860    

Indirect Value

  $80,818,933      
Total Shares   119,950,854      
Total Value   $100,888,793      


Color Kinetics Inc
 $0 Receptos, Inc.
 $0 Editas Medicine, Inc.
 $20,059,135 Seres Therapeutics, Inc.
 $10,724 Moderna, Inc.
 $0 Color Kinetics Inc
 $0 Receptos, Inc.
 $0 Editas Medicine, Inc.
 $20,059,135 Seres Therapeutics, Inc.
 $10,724 Moderna, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    10   
    0    

     Stock price went up :

    3   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -22.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Color Kinetics Inc CLRK Director 2005-10-03 83,062 2005-10-03 12,000    Premium*  
            Agenus Inc AGEN Director 2006-12-14 0 2006-12-14 0    Premium*  
            Helicos Biosciences Corp HLCSQ Director, 10% Owner 2009-09-18 0 2009-09-18 12,192,640    Premium*  
            Receptos, Inc. RCPT 10% Owner 2013-11-18 1,693,551 0    Premium*  
            DNIB Upwind Inc BIND Director, 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Bg Medicine, Inc. BGMD Director, 10% Owner 2015-12-09 0 2015-12-09 1,286,274    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-02-08 3,964,256 2016-02-08 991,060    Premium*  
            Selecta Biosciences Inc SELB 10% Owner 2016-06-27 0 2016-06-27 1,651,862    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2021-02-08 14,907,627    Premium*  
            Transmedics Group, Inc. TMDX 10% Owner 0 2019-10-29 120,595    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 2019-06-18 15,141 2022-07-05 17,617,352    Premium*  
            Moderna, Inc. MRNA 2024-06-12 2,314,015 2024-06-12 4,632,149    Premium*  
            Axcella Health Inc. AXLA 10% Owner 2020-05-18 0 2022-10-13 8,850,296    Premium*  
            Evelo Biosciences Inc EVLO 2020-06-29 0 2023-07-11 4,977,588    Premium*  
            Codiak Biosciences, Inc. CDAK 10% Owner 0 2022-09-15 1,674,869    Premium*  
            Foghorn Therapeutics Inc. FHTX 10% Owner 2020-10-27 0 2020-10-27 1,851,801    Premium*  
            Sigilon Therapeutics, Inc. SGTX 10% Owner 2020-12-08 0 2023-08-11 0    Premium*  
            Sana Biotechnology, Inc. SANA 10% Owner 2021-02-08 0 2023-09-13 581,695    Premium*  
            Rubius Therapeutics, Inc. RUBY Director, 10% Owner 2021-03-19 0 2021-03-19 17,253,519    Premium*  
            Omega Therapeutics, Inc. OMGA Director, 10% Owner 2021-08-03 0 2023-02-27 21,716,886    Premium*  
* Premium Members only  

Records found :    149         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
MRNA Moderna, Inc. Director   –       •      –    2022-09-14 4 AS $134.00 $1,340,000 D/D (10,000) 2,417,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-09-21 4 AS $130.37 $1,303,700 D/D (10,000) 2,407,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-09-28 4 AS $123.58 $1,235,800 D/D (10,000) 2,397,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-10-05 4 AS $122.40 $1,224,000 D/D (10,000) 2,387,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-10-12 4 AS $135.36 $1,353,600 D/D (10,000) 2,377,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-10-19 4 AS $132.50 $1,325,000 D/D (10,000) 2,367,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-11-02 4 AS $154.20 $1,542,000 D/D (10,000) 2,347,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-11-09 4 AS $162.50 $1,625,000 D/D (10,000) 2,337,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-11-16 4 AS $184.25 $1,842,500 D/D (10,000) 2,327,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-11-30 4 AS $173.52 $1,735,200 D/D (10,000) 2,307,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-12-07 4 AS $172.16 $1,721,600 D/D (10,000) 2,297,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-12-14 4 AS $195.00 $1,950,000 D/D (10,000) 2,287,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-12-21 4 AS $201.70 $2,017,000 D/D (10,000) 2,277,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-01-11 4 AS $188.57 $1,885,700 D/D (10,000) 2,257,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-01-18 4 AS $200.20 $2,002,000 D/D (10,000) 2,247,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-01-25 4 AS $194.33 $1,943,300 D/D (10,000) 2,237,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-02-08 4 AS $164.60 $3,356,761 D/D (20,000) 2,217,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-02-15 4 AS $173.17 $1,731,700 D/D (10,000) 2,207,209 0 -
OMGA Omega Therapeutics, Inc. Director   –       •       •   2023-02-27 4 B $5.78 $19,208,732 I/I 3,323,310 1,329,324 2.25 %
MRNA Moderna, Inc. Director   –       •      –    2023-05-31 4 AS $125.69 $1,910,322 D/D (15,000) 2,172,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-06-07 4 AS $125.76 $1,888,601 D/D (15,000) 2,157,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-06-14 4 AS $125.43 $1,892,627 D/D (15,000) 2,142,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-07-05 4 AS $123.46 $1,870,933 D/D (15,000) 2,097,209 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-09-13 4 AS $108.21 $1,645,522 D/D (15,000) 2,221,931 0 -

  149  Records found
  1   2   3   4   5   6     
  Page 6 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed